These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 29986618)
1. Disease Progression in a Patient With Indolent T-Cell Lymphoproliferative Disease of the Gastrointestinal Tract. Perry AM; Bailey NG; Bonnett M; Jaffe ES; Chan WC Int J Surg Pathol; 2019 Feb; 27(1):102-107. PubMed ID: 29986618 [TBL] [Abstract][Full Text] [Related]
2. Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract-What Have We Learned in the Last Decade? Wang XG; Yin WH; Wang HY Lab Invest; 2024 Apr; 104(4):102028. PubMed ID: 38382808 [TBL] [Abstract][Full Text] [Related]
3. An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow. Wang X; Ng CS; Chen C; Yu G; Yin W Diagn Pathol; 2018 Oct; 13(1):82. PubMed ID: 30342536 [TBL] [Abstract][Full Text] [Related]
4. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update. Matnani R; Ganapathi KA; Lewis SK; Green PH; Alobeid B; Bhagat G Hematol Oncol; 2017 Mar; 35(1):3-16. PubMed ID: 27353398 [TBL] [Abstract][Full Text] [Related]
5. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update. van Vliet C; Spagnolo DV Pathology; 2020 Jan; 52(1):128-141. PubMed ID: 31727264 [TBL] [Abstract][Full Text] [Related]
6. Indolent T-cell lymphoproliferative disorder of gastrointestinal tract with unusual clinical courses: report of 6 cases and literature review. Fan W; Niu L; He H; Yuan J; Yuan F; Shi X; Wang Y; Chen M; Huang M; Zhou F; Xu J; Chen Q Virchows Arch; 2023 Apr; 482(4):729-743. PubMed ID: 36472661 [TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal T- and NK-cell lymphomas and indolent lymphoproliferative disorders. Soderquist CR; Bhagat G Semin Diagn Pathol; 2020 Jan; 37(1):11-23. PubMed ID: 31522873 [TBL] [Abstract][Full Text] [Related]
8. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Perry AM; Warnke RA; Hu Q; Gaulard P; Copie-Bergman C; Alkan S; Wang HY; Cheng JX; Bacon CM; Delabie J; Ranheim E; Kucuk C; Hu X; Weisenburger DD; Jaffe ES; Chan WC Blood; 2013 Nov; 122(22):3599-606. PubMed ID: 24009234 [TBL] [Abstract][Full Text] [Related]
9. Indolent T-Cell Lymphoproliferative Disease of the GI Tract: Insights for Better Diagnosis, Prognosis, and Appropriate Therapy. Küçük C; Wei L; You H Front Oncol; 2020; 10():1276. PubMed ID: 32850389 [TBL] [Abstract][Full Text] [Related]
10. T-cell LPD of the GIT: first do no harm. Said J Blood; 2013 Nov; 122(22):3548-50. PubMed ID: 24263952 [TBL] [Abstract][Full Text] [Related]
11. Feline low-grade intestinal T cell lymphoma: a unique natural model of human indolent T cell lymphoproliferative disorder of the gastrointestinal tract. Freiche V; Cordonnier N; Paulin MV; Huet H; Turba ME; Macintyre E; Malamut G; Cerf-Bensussan N; Molina TJ; Hermine O; Bruneau J; Couronné L Lab Invest; 2021 Jun; 101(6):794-804. PubMed ID: 33692440 [TBL] [Abstract][Full Text] [Related]
12. Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: a tricky diagnosis of a gastric case. Zanelli M; Zizzo M; Sanguedolce F; Martino G; Soriano A; Ricci S; Castro Ruiz C; Annessi V; Ascani S BMC Gastroenterol; 2020 Oct; 20(1):336. PubMed ID: 33054767 [TBL] [Abstract][Full Text] [Related]
13. Peripheral T-cell lymphoma with gastrointestinal involvement and indolent T-lymphoproliferative disorders of the gastrointestinal tract. Kohri M; Tsukasaki K; Akuzawa Y; Tanae K; Takahashi N; Saeki T; Okamura D; Ishikawa M; Maeda T; Kawai N; Matsuda A; Arai E; Arai S; Asou N Leuk Res; 2020 Apr; 91():106336. PubMed ID: 32151888 [TBL] [Abstract][Full Text] [Related]
14. Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas. Montes-Moreno S; King RL; Oschlies I; Ponzoni M; Goodlad JR; Dotlic S; Traverse-Glehen A; Ott G; Ferry JA; Calaminici M Virchows Arch; 2020 May; 476(5):667-681. PubMed ID: 31773249 [TBL] [Abstract][Full Text] [Related]
15. Indolent T-cell lymphoproliferative disease with synchronous diffuse large B-cell lymphoma: A case report. Guo L; Wen Z; Su X; Xiao S; Wang Y Medicine (Baltimore); 2019 Apr; 98(17):e15323. PubMed ID: 31027102 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases. Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684 [TBL] [Abstract][Full Text] [Related]
18. Indolent NK-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract - a Report of two Cases of a new Provisional Entity on the World Health Organization Classification of Hematolymphoid Tumors. Alves de Castro JV; Costa FD; Ferreira CR Int J Surg Pathol; 2023 Aug; 31(5):596-599. PubMed ID: 35903908 [TBL] [Abstract][Full Text] [Related]
19. A unique case of an indolent CD56-positive T-cell lymphoproliferative disorder of the gastrointestinal tract: a lesion potentially misdiagnosed as natural killer/T-cell lymphoma. McElroy MK; Read WL; Harmon GS; Weidner N Ann Diagn Pathol; 2011 Oct; 15(5):370-5. PubMed ID: 20952278 [TBL] [Abstract][Full Text] [Related]
20. VITREORETINAL INVOLVEMENT BY INDOLENT T-CELL LYMPHOPROLIFERATIVE DISORDER OF THE GASTROINTESTINAL TRACT DIAGNOSED BY FLUORESCENCE IN SITU HYBRIDIZATION. Salman AR; Ferenchak K; Olsen TW; Smith WM; Ketterling RP; McPhail ED; Salomao DR; Dalvin LA Retin Cases Brief Rep; 2023 Sep; 17(5):572-576. PubMed ID: 37490925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]